The Latest Breaking News from Medicare

Stanford Study Identifies Why Ozempic and Wegovy Don't Work in About 1 in 10 Patients

A Stanford Medicine study identifies a genetic variant in about 10% of people that may reduce response to GLP-1 drugs like Ozempic and Wegovy, offering new insight into why these widely used diabetes and weight-loss treatments fail for some patients and highlighting the future of precision medicine in Type 2…

Medical Daily · Jun 7

CareDx Highlights 39% Q1 Growth, Naveris Oncology Push at Jefferies

CareDx (NASDAQ:CDNA) executives outlined the company’s growth strategy, first-quarter performance and pipeline priorities during a presentation at the Jefferies Healthcare Conference, emphasizing transplant diagnostics, specialty oncology and digital workflow integration. John Hanna, chief executiv

MarketBeat · Jun 7

Here's where U.S. debt may become unsustainable as interest payments trigger a default crisis that even steep tax hikes can't fix

"Bond markets unravel sooner when investors believe that the government will not restore fiscal sustainability."

Fortune · Jun 6

Hospital-at-Home: The Medicare Option Few Seniors Know About

Most people assume that a hospital stay means spending days or weeks in a hospital bed surrounded by monitors, alarms, and unfamiliar surroundings. What many...

Saving Advice · Jun 5

7 Hidden Medicare Savings Programs That Pay Your Part B Premium

Healthcare expenses are one of the top expenses that all seniors face. While Medicare is in place to make it more affordable, premiums continue to...

Saving Advice · Jun 5

With Nation's Highest Diabetes Rate, San Antonio Faces Major Shift as Medicare Prepares $50 Wegovy Coverage

With diabetes rates among the highest in the U.S., San Antonio could see major change as Medicare's new $50 Wegovy coverage begins July 1, expanding access for eligible residents.

Medical Daily · Jun 5

What This Year's Biggest Medicare Changes Mean for You

Some drug prices are falling, other costs are climbing, and new rules abound. Here's what you need to know.

Kiplinger · Jun 5

We’ve been testing therapy like it’s a pill – and some patients are paying the price

If you’ve had therapy, particularly if you got it through a public healthcare system like the NHS in the UK or Medicare in Australia, there’s a good chance it was cognitive behavioural therapy (CBT). Even with private health insurance, if you want therapy, the one you are most likely to…

The Conversation · Jun 5

How Zoe Heineman's Lifelong Fight for Diabetes Access Led Her to The Intersection of Healthcare Research & AI

The economic impact of diabetes continues to be significant. It is estimated that diagnosed diabetes generated approximately $413 billion in total costs in the United States, including direct medical expenses and indirect costs associated with lost productivity.

International Business Times · Jun 4

From Crisis to Possible Cure Path: San Antonio Battles Highest Diabetes Rates as Wegovy and Medicare (United States) Expansion Offer New Hope

Diabetes care is entering a new era in San Antonio as the Wegovy pill and expanded Medicare coverage offer new hope for preventing and managing diabetes in one of America's hardest-hit cities.

Medical Daily · Jun 4